
Oasis Biofarm develops antibodies, biological reagents and detection solutions for biomedical research. The company has established particular expertise in neurological biomarkers and cell-type-specific targets.
Its research products support Western blot, immunofluorescence, immunohistochemistry and other protein detection methods. Researchers can use these reagents to study neural cells, disease-associated proteins and changes in tissue structure.
Neuroscience represents a central area within the Oasis Biofarm antibody portfolio. The brand offers antibodies for identifying neurons, glial cells and neural progenitor cells.
Relevant targets cover several major cell populations in the central nervous system:
These antibodies support studies of neural development, cell differentiation, neuroinflammation and nervous system injury. They can also help researchers examine changes in cell populations within brain and spinal cord tissue.
Oasis Biofarm focuses on biomarkers associated with Alzheimer’s disease, Parkinson’s disease and other neurodegenerative conditions.
Researchers can use relevant antibodies to study protein aggregation, neuronal loss, synaptic dysfunction, oxidative stress and inflammatory responses. Suitable products may support both basic research and early biomarker evaluation.
Neurodegenerative disease studies often require antibodies with clear tissue localization. Researchers should therefore confirm the tested species, sample type and recommended application before ordering.
Alzheimer’s disease research examines amyloid pathology, tau-associated changes, synaptic damage and neuroinflammation. Oasis Biofarm offers research antibodies for selected proteins and cellular markers involved in these processes.
The antibodies may support immunofluorescence, immunohistochemistry and Western blot experiments. Researchers can use them to examine disease models, brain tissue and cultured neural cells.
Product selection should reflect the model species and target isoform. Researchers should also review whether an antibody recognizes total protein or a specific modification.
Parkinson’s disease studies frequently investigate dopaminergic neurons, protein aggregation, mitochondrial function and neuroimmune responses.
Oasis Biofarm antibodies can support the identification of selected neuronal and glial markers in Parkinson’s disease models. These reagents may help researchers evaluate changes in neuronal survival, microglial activation and disease-associated protein expression.
Astrocytes, microglia and oligodendrocytes play important roles in neural homeostasis and disease progression. Oasis Biofarm offers antibodies for distinguishing these cell populations in tissue and cell-based experiments.
Researchers can apply these markers to investigate:
Using antibodies from different host species can simplify double-label and multiplex immunofluorescence experiments. Researchers should confirm host compatibility before designing an antibody panel.
Oasis Biofarm also supplies antibodies for stem cell biology and neural differentiation studies. Relevant markers help researchers identify stem cells, neural progenitors and differentiated neural cell types.
These products support research into cell fate, lineage development and regenerative mechanisms. They may also help evaluate differentiation efficiency in cell culture models.
Marker expression can change with culture conditions and differentiation stage. A combination of positive and negative markers usually provides more reliable cell identification.
Immunofluorescence is an important application within the Oasis Biofarm portfolio. Many neuroscience experiments require clear cellular localization and low background staining.
Researchers can use suitable antibodies to identify specific neural cell types or examine protein distribution within tissues. Multi-label experiments can reveal relationships between neurons, glial cells and disease-associated proteins.
Before starting an experiment, users should confirm fixation conditions, antigen retrieval requirements and recommended antibody dilution. These factors can significantly affect staining quality.
Selected Oasis Biofarm antibodies support Western blot analysis of cell and tissue lysates. This method allows researchers to examine target expression and approximate molecular weight.
Sample preparation, protein loading and membrane selection can influence the final result. Researchers should consult the product datasheet for validated sample types and recommended conditions.
Immunohistochemistry allows researchers to examine protein expression within tissue architecture. Oasis Biofarm antibodies for neural markers can support studies of brain regions, disease pathology and cellular distribution.
Researchers should confirm compatibility with frozen or paraffin-embedded sections. Fixation time and antigen retrieval methods may also require optimization.
In addition to research antibodies, Oasis Biofarm works on antibody raw materials and detection technologies for neurological biomarkers. These capabilities connect antibody development with assay development and translational research.
Potential application areas include neurodegenerative diseases, neurological autoimmune conditions and brain tumor research. However, users must distinguish research-use products from registered diagnostic products.
Products marked for research use only should not be used for clinical diagnosis. Buyers should review the current regulatory status and intended use of each product.
Start with the target name and intended research application. Next, confirm the tested species, sample type, antibody host and clonality.
For immunofluorescence, consider the host species of every primary antibody in the panel. The secondary antibodies must distinguish each primary antibody without cross-reactivity.
For Western blot, review the expected molecular weight and validated lysate types. For tissue staining, check the fixation method and section type.
Researchers should also compare validation images and recommended dilution ranges. When available, published references can provide useful experimental guidance.
Biolterna helps international laboratories and distributors source Oasis Biofarm antibodies and research reagents from China.
Provide the Oasis Biofarm catalog number, product name, pack size and required quantity when requesting a quotation. If the catalog number is unavailable, share the target, species and intended application.
Biolterna can also help identify products for neuroscience, neurodegenerative disease and neural cell marker research. We support product confirmation, consolidated sourcing and international shipment coordination.
Official website link: